Product Information

ZEPBOUND 10 MG/0.5 ML PEN is a brand product labeled by Eli Lilly and Company, priced at $526.0698 per ML under NDC 00002247180. Its NADAC has been published 143 times since Feb 21, 2024.

FDA first approved this application on Nov 8, 2023.

ZEPBOUND 10 MG/0.5 ML PEN

tirzepatide
$526.0698per ML

Strength

10 mg/.5mL

NDC

00002247180

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

10/21/2026

Active Ingredients

TIRZEPATIDE

Approval Type

New Drug (NDA)

FDA Application

NDA217806

FDA Approved

11/8/2023

On Market Since

11/8/2023

Pharmacological Classes

G-Protein-linked Receptor Interactions
GLP-1 Receptor Agonist
Glucagon-like Peptide-1 (GLP-1) Agonists
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

Price Statistics

The NADAC for ZEPBOUND 10 MG/0.5 ML PEN has been published 143 times since Feb 21, 2024, and over the history we have for it it has risen 3.2%. The table below summarizes its recorded NADAC range and movement.

Current price$526.0698 per ML
All-time high$541.9428 (Feb 25, 2026)
All-time low$509.9572 (Feb 21, 2024)
52-week high$541.9428
52-week low$525.7717
Median price$525.8193
Average price$520.8650
Largest weekly change+3.0% (Feb 25, 2026)
Weeks tracked143
Tracking sinceFeb 21, 2024

Price History

1W

0.0%

1M

+0.0%

3M

-0.0%

6M

+0.0%

1Y

+0.0%

3Y

N/A

5Y

N/A

All

+3.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ZEPBOUND 10 MG/0.5 ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for ZEPBOUND 10 MG/0.5 ML PEN, manufactured by Eli Lilly and Company, is $526.0698 per ML (NDC 00002247180), effective Nov 11, 2026.

How has the price of ZEPBOUND 10 MG/0.5 ML PEN changed over time?

Over the history we have for it, the NADAC for ZEPBOUND 10 MG/0.5 ML PEN has risen 3.2%. It has been tracked across 143 weekly CMS publications since Feb 21, 2024.

What are the highest and lowest recorded NADAC prices for ZEPBOUND 10 MG/0.5 ML PEN?

Since Feb 21, 2024, the NADAC for ZEPBOUND 10 MG/0.5 ML PEN has ranged from a low of $509.9572 (Feb 21, 2024) to a high of $541.9428 (Feb 25, 2026), with a median of $525.8193 per ML.

Are there cheaper alternatives to ZEPBOUND 10 MG/0.5 ML PEN?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZEPBOUND 10 MG/0.5 ML PEN in a comparable dosage form, but none are currently priced below it.

Who manufactures ZEPBOUND 10 MG/0.5 ML PEN?

ZEPBOUND 10 MG/0.5 ML PEN (NDC 00002247180) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.